儿童及性少数与性别少数人群的内分泌健康与医疗差异:内分泌学会科学声明
该科学声明聚焦儿童及性少数与性别少数(LGBTQIA)人群的内分泌疾病差异,涵盖生长障碍、青春期、代谢性骨病、1型与2型糖尿病、糖尿病前期及肥胖。声明指出非西班牙裔白人男性更易因矮身材就诊,少数种族及男性在青春期与峰值骨量研究中代表性不足,LGBTQIA人群面临歧视与内分泌诊疗多重障碍,需多层次干预及纳入纵向生命历程研究。
要点
- 非西班牙裔白人男性较女性及非白人儿童更易因矮身材就医。
- 少数种族及男性在青春期发育与峰值骨量研究中代表性不足,现行标准基于欧洲人群。
- 少数种族青少年肥胖、1型与2型糖尿病疾病负担更高,糖尿病技术及减重手术可及性更低。
核心结论
- 内分泌诊疗中的健康与医疗差异由卫生系统基本结构、研究模式及影响医疗可及性与健康社会决定因素的政策所持续。
- 需多层次干预以解决这些差异,并纳入种族、族裔及LGBTQIA人群的纵向生命历程研究以评估生长、青春期及峰值骨量达成。
- 生长与发育图表可能需要针对非欧洲人群进行调整,卫生政策应重新制定以消除肥胖和/或糖尿病儿童及LGBTQIA儿童与成人获得综合医疗、治疗和技术进步的障碍。
- 公共卫生干预应包括收集准确的人口学和社会需求数据(含健康社会决定因素与健康结局的交集)及实施人群健康水平干预。
研究设计与样本
- 该文件为内分泌学会科学声明,扩展了该学会2012年声明,聚焦儿童人群及性少数与性别少数人群的内分泌疾病差异。
- 撰写组聚焦高患病状况:生长障碍、青春期、代谢性骨病、1型糖尿病(T1D)、2型糖尿病(T2D)、糖尿病前期及肥胖。
- 声明涵盖儿童及成人女同性恋、男同性恋、双性恋、跨性别、酷儿、间性及无性恋(LGBTQIA)人群。
主要发现
- 与女性和非白人儿童相比,非西班牙裔白人男性更可能因矮身材而就医。
- 种族和族裔多样化人群及男性在青春期发育和峰值骨量达成研究中代表性不足,现行标准基于欧洲人群。
- 与成人一样,种族和族裔少数青少年承受更高的肥胖、T1D和T2D疾病负担,且获得糖尿病治疗技术和减重手术的机会更少。
- LGBTQIA青少年和成人因性取向和性别认同被病理化、缺乏文化胜任力的照护提供者及政策而面临歧视和内分泌诊疗的多重障碍。
临床怎么用
- 声明提出需多层次干预以解决所描述的内分泌诊疗差异。
- 声明提出需将种族、族裔和LGBTQIA人群纳入纵向生命历程研究以评估生长、青春期和峰值骨量达成。
- 声明提出生长和发育图表可能需要针对非欧洲人群进行调整。
- 声明提出需扩展这些研究以理解针对这些人群异常发育干预的临床和生理后果。
- 声明提出卫生政策应重新制定以消除肥胖和/或糖尿病儿童及LGBTQIA儿童和成人获得综合医疗、治疗和技术进步的障碍。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Endocrine care of pediatric and adult patients continues to be plagued by health and health care disparities that are perpetuated by the basic structures of our health systems and research modalities, as well as policies that impact access to care and social determinants of health. This scientific statement expands the Society's 2012 statement by focusing on endocrine disease disparities in the pediatric population and sexual and gender minority populations. These include pediatric and adult lesbian, gay, bisexual, transgender, queer, intersex, and asexual (LGBTQIA) persons. The writing group focused on highly prevalent conditions-growth disorders, puberty, metabolic bone disease, type 1 (T1D) and type 2 (T2D) diabetes mellitus, prediabetes, and obesity. Several important findings emerged. Compared with females and non-White children, non-Hispanic White males are more likely to come to medical attention for short stature. Racially and ethnically diverse populations and males are underrepresented in studies of pubertal development and attainment of peak bone mass, with current norms based on European populations. Like adults, racial and ethnic minority youth suffer a higher burden of disease from obesity, T1D and T2D, and have less access to diabetes treatment technologies and bariatric surgery. LGBTQIA youth and adults also face discrimination and multiple barriers to endocrine care due to pathologizing sexual orientation and gender identity, lack of culturally competent care providers, and policies. Multilevel interventions to address these disparities are required. Inclusion of racial, ethnic, and LGBTQIA populations in longitudinal life course studies is needed to assess growth, puberty, and attainment of peak bone mass. Growth and development charts may need to be adapted to non-European populations. In addition, extension of these studies will be required to understand the clinical and physiologic consequences of interventions to address abnormal development in these populations. Health policies should be recrafted to remove barriers in care for children with obesity and/or diabetes and for LGBTQIA children and adults to facilitate comprehensive access to care, therapeutics, and technological advances. Public health interventions encompassing collection of accurate demographic and social needs data, including the intersection of social determinants of health with health outcomes, and enactment of population health level interventions will be essential tools.
引用
- Diaz-Thomas AM, Golden SH, Dabelea DM, et al. Endocrine Health and Health Care Disparities in the Pediatric and Sexual and Gender Minority Populations: An Endocrine Society Scientific Statement. J Clin Endocrinol Metab. 2023. PMID: 37191578. doi:10.1210/clinem/dgad124
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。